MRNA - IN WAVE B CORRECTION PHASE - OVERALL BEARISH
MRNA, is currently undergoing correction phase. To be specific, the prices are forming counterwaves ABC of smaller degree (red labelling of ABC) as part of higher degree of Wave B (black labelling) formation.
It is predicted the higher degree of Wave B will end at around USD163 before making bigger downtrend movement of Wave C. The target for Wave C is to hit minimal of around USD79 (61.8% FIBO correction), or to the worst of around USD49.6 (78.6% FIBO correction).
A stock of potential shorting opportunities on rebound.
Happy trading.
It is predicted the higher degree of Wave B will end at around USD163 before making bigger downtrend movement of Wave C. The target for Wave C is to hit minimal of around USD79 (61.8% FIBO correction), or to the worst of around USD49.6 (78.6% FIBO correction).
A stock of potential shorting opportunities on rebound.
Happy trading.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。